In the title compound, C 14 H 18 ClNS, the 2,3-dihydro-1,3thiazole ring adopts an envelope with the S,N-bound C atom at the flap and the cyclohexane ring adopts a chair conformation. In the crystal, N-HÁ Á ÁS hydrogen bonds with C(5) motifs connect the molecules into chains parallel to the c axis.
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5-Chloro-4′-ethyl-3H-spiro[1,3-benzothiazole-2,1′-cyclohexane]
Mehmet Akkurt, Gökçe Cihan-Üstündağ, Gültaze Çapan, Sevim Türktekin-Çelikesir and Muhammad Nawaz Tahir Comment Efforts to design, synthesize and screen new molecules that mimic the actions of currently available chemotherapeutics have resulted in numerous promising candidates incorporating the benzothiazole moiety. Benzothiazolines and spirobenzothiazolines, the cyclic products obtained by the condensation of aldehydes and ketones with 2-aminothiophenoles were previously reported to exhibit antitubercular (Palmer et al., 1971 ), analgesic (Coudert et al., 1988 and antioxidant (Karalı et al., 2010) properties. In this context, the title compound was prepared by the condensation of 4-ethylcyclohexanone with 2-amino-4-chlorothiophenol in an attempt to obtain a new molecule with antioxidant action and to establish its definite structure via analytical, spectroscopic and crystallographic data.
In the title compound (I), (Fig. 1) , the S1/N1/C1/C6/C7 2,3-dihydro-1,3-thiazole ring adopts an envelope conformation with the C7 atom at the flap [puckering parameters (Cremer & Pople, 1975) 
The C7-C12 cyclohexane ring adopts a chair conformation [puckering parameters: Q T = 0.552 (2) Å, θ = 180.0 (2) ° and φ = 337 (7)°]. The bond lengths of (I) are within the expected values (Allen et al., 1987) .
In the crystal, molecules are linked by intermolecular N1-H1N···S1 hydrogen bonds (Table 1 and The packing and hydrogen bonding of the title molecule in the unit cell, viewing down c axis. H atoms not involved in hydrogen bonds have been omitted for clarity.
Crystal data 
Special details
Geometry. Bond distances, angles etc. have been calculated using the rounded fractional coordinates. All su's are estimated from the variances of the (full) variance-covariance matrix. The cell e.s.d.'s are taken into account in the estimation of distances, angles and torsion angles Refinement. Refinement on F 2 for ALL reflections except those flagged by the user for potential systematic errors. Weighted R-factors wR and all goodnesses of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The observed criterion of F 2 > σ(F 2 ) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq Cl1 0.49813 (9) 0.45066 (8 
Geometric parameters (Å, º)
Cl1-C4 1.742 (2) C13-C14 1.515 (4) S1-C1 1.762 (2) C2-H2 0.9300 S1-C7 1.854 (2) 
